Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Medtronic secures $337m for diabetes portfolio

Despite a dipping diabetes tech market stemming from the Covid-19 crisis, Medtronic has netted a guarantee of up to $337m in R&D funding for its diabetes portfolio.

Close
Close
Close

Go Top